sn132d
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2019 (NCT04080024)
Timeline
Indications
Mechanism of action
- Unspecified targetContrast agent
contrast agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05664828 | Phase 2 | Nov 17, 2022 | Spago Nanomedical AB |
| NCT04080024 | Phase 1 | Sep 30, 2019 | Clinical Trial Consultants AB, Spago Nanomedical AB |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Spago Nanomedical AB | For profit | 2 | 2 | 2 | 2019 |
| Clinical Trial Consultants AB | For profit | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1